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Acute lung injury (ALI) induces inﬂammation that disrupts the normal alveolarcapillary endothelial barrier which impairs gas exchange to induce hypoxemia that
reﬂexively increases respiration. The neural mechanisms underlying the respiratory
dysfunction during ALI are not fully understood. The purpose of this study was to
investigate the role of the chemoreﬂex in mediating abnormal ventilation during
acute (early) and recovery (late) stages of ALI. We hypothesized that the increase in
respiratory rate (fR) during post-ALI is mediated by a sensitized chemoreﬂex. ALI
was induced in male Sprague-Dawley rats using a single intra-tracheal injection of
bleomycin (Bleo: low-dose = 1.25 mg/Kg or high-dose = 2.5 mg/Kg) (day 1) and
respiratory variables- fR, Vt (Tidal Volume), and VE (Minute Ventilation) in response
to 10% hypoxia (10% O2, 0% CO2) and 5% hypercapnia/21% normoxia (21% O2, 5%
CO2) were measured weekly from W0-W4 using whole-body plethysmography
(WBP). Our data indicate sensitization (∆fR = 93 ± 31 bpm, p < 0.0001) of the
chemoreﬂex at W1 post-ALI in response to hypoxic/hypercapnic gas challenge in
the low-dose bleo (moderate ALI) group and a blunted chemoreﬂex (∆fR = −0.97 ±
42 bpm, p < 0.0001) at W1 post-ALI in the high-dose bleo (severe ALI)
group. During recovery from ALI, at W3-W4, both low-dose and high-dose
groups exhibited a sensitized chemoreﬂex in response to hypoxia and
normoxic-hypercapnia. We then hypothesized that the blunted chemoreﬂex at
W1 post-ALI in the high-dose bleo group could be due to near maximal tonic
activation of chemoreceptors, called the “ceiling effect”. To test this possibility, 90%
hyperoxia (90% O2, 0% CO2) was given to bleo treated rats to inhibit the
chemoreﬂex. Our results showed no changes in fR, suggesting absence of the
tonic chemoreﬂex activation in response to hypoxia at W1 post-ALI. These data
suggest that during the acute stage of moderate (low-dose bleo) and severe (highdose bleo) ALI, chemoreﬂex activity trends to be slightly sensitized and blunted,
respectively while it becomes signiﬁcantly sensitized during the recovery stage.
Future studies are required to examine the molecular/cellular mechanisms
underlying the time-course changes in chemoreﬂex sensitivity post-ALI.
KEYWORDS

acute lung injury, acute respiratory distress syndrome, bleomycin, chemoreceptors,
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Introduction
Acute lung injury (ALI) and its clinical correlate, the acute
respiratory distress syndrome (ARDS), results due to disruption
of the normal capillary endothelial barrier and invokes
perturbations of ventilatory control (Young et al., 2019).
Acute respiratory failure affects approximately 200,000 new
cases each year in the US alone and accounts for 10% of ICU
admissions with a high mortality and morbidity (Mowery et al.,
2020). Current treatment therapies are focused on resolution of
the lung disorder by ﬂuid management, prone positioning,
pharmacological interventions, and mechanical ventilation.
ALI/ARDS causes marked diffuse alveolar damage,
endothelial cell damage and pulmonary interstitial and
alveolar edema that results in increased intrapulmonary
shunt and dead space as well as atelectasis leading to a
decreased functional lung size (Bernard et al., 1994; Ghio
et al., 2001; Spinelli et al., 2020). This causes an impairment
in gas exchange inducing hypoxemia, a hypoxic ventilatory
response (HVR) and a reﬂexive increase in respiratory rate (fR)
(Bernard et al., 1994; Jacono et al., 2006; Spinelli et al., 2020).
The neural mechanism that drives this increase in fR during ALI
is not fully understood.
Peripheral chemoreceptors in the carotid bodies (CBs)
located at the bifurcation of the common carotid artery, are
the ﬁrst responders to hypoxia. A decrease in arterial pO2 causes
the glomus cells (type 1 cells) of the CBs to depolarize, increase
intracellular calcium levels and closure of potassium channels to
cause neurotransmitter release. The chemosensory afferent input
from glomus cells then travels to the respiratory network in the
brain stem through the carotid sinus nerve (CSN) which projects
to the nucleus solitarius tractus (NTS) and respiratory
motoneurons to induce a hypoxic ventilatory response (Sun
et al., 1999; Prabhakar, 2000). The HVR in the early stage of
ALI has been examined (Jacono et al., 2006; Huxtable et al., 2011)

FIGURE 1
Timeline showing experimental design.
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but little is known about the exact time-dependent changes in
chemoreﬂex sensitivity in acute ALI and during the recovery of
ALI. The speciﬁc objective of our study was to look at the time
dependent respiratory changes in chemoreﬂex function in
response to hypoxic and hypercapnic stimuli before ALI
(Week 0; W0) and weekly for up to 4 weeks (W1-W4) post-ALI.

Methods
Ethical approval
Animals were housed in a temperature-controlled environment
(22°C–25°C) with a 12 h light–dark cycle and ad libitum access to
food and water, in accordance with standards set by the National
Institutes of Health Guidelines for the Care and Use of Laboratory
Animals. All experimental protocols were approved by the
Institutional Animal Care and Use Committee (IACUC) of the
University of Nebraska Medical Center (protocol ID no. 17-00603 FC).

Animals
Thirty-three adult male Sprague-Dawley rats (2–3 months
old) were used for these experiments. Animals were housed onsite in a controlled temperature environment (22°C–25°C) with a
12-h light-dark cycle and ad libitum access to food and water and
were allowed to acclimate for 3 days to their new environment
prior to the experiment. A small number of rats (1 high-dose bleo
rat) died during experimentation after W2 post-bleo
administration stemming from severe lung injury. All animal
experimentation (collection of ventilatory parameters during rest
and during hypoxic/hypercapnic gas exposure) was performed
during the day (9.00–1600 h). Delivery of bleo (or saline) was
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TABLE 1 Mean body weight and mean change in body weight (in grams) for sham, low-dose bleo and high-dose bleo rats.

Mean body weight (grams)

Mean Δ body weight (grams)

W0

W1

W2

W3

W4

ΔW1

ΔW2

ΔW3

ΔW4

Sham (n = 14)

337 ± 41

405 ± 42***

443 ± 45****

472 ± 45****

485 ± 48****

69 ± 20

107 ± 27

136 ± 36

148 ± 35

Low-dose bleo (n = 10)

465 ± 114

472 ± 80

488 ± 66

506 ± 62

522 ± 55

6.6 ± 50

23 ± 60

41 ± 61

57 ± 65

High-dose bleo (n = 9)

301 ± 66

283 ± 71

313 ± 93

386 ± 65

412 ± 55ǂ

-19 ± 20

11 ± 56

77 ± 23

103 ± 21

Values are mean ± SD; One-way ANOVA with bonferroni multiple comparison test; bleo indicates bleomycin. ***p = 0.0004 (Sham-W0 vs. W1), ****p < 0.0001 (Sham- W0 vs. W2, W3 and
W4), ǂp = 0.0117 (High-dose bleo- W0 vs. W4).

TABLE 2 Mean resting respiratory rate (fR) (in BPM) for sham, low-dose bleo and high-dose bleo rats.

Mean resting fR (BPM)
W0

W1

W2

W3

W4

Sham (n = 14)

108 ± 12

104 ± 15

107 ± 26

118 ± 25

99 ± 16

Low-dose bleo (n = 10)

97 ± 16

193 ± 55###

151 ± 41##

125 ± 31

103 ± 12

High dose-bleo (n = 9)

117 ± 21

333 ± 46ǂǂǂǂ

238 ± 81ǂǂ

198 ± 48ǂǂǂ

164 ± 47ǂǂ

Values are mean ± SD; One-way ANOVA with bonferroni multiple comparison test; fR indicates respiratory rate; bleo indicates bleomycin. ##p = 0.007 (Low-dose bleo- W0 vs. W2), ###p =
0.001 (Low-dose bleo- W0 vs. W1), ǂǂp = 0.007 (High-dose bleo- W0 vs. W2), ǂǂp = 0.01 (High-dose bleo- W0 vs. W4), ǂǂǂp = 0.001 (High-dose bleo- W0 vs. W3), ǂǂǂǂp = 0.0001 (Highdose bleo- W0 vs. W1)

performed within our animal housing center. At the end of the
experimental protocol, all animals were humanely euthanized
with an overdose of pentobarbital sodium (150 mg/kg, IV).
Euthanasia was conﬁrmed by removal of vital organs and lung
tissue was collected for further analysis. An experimental
timeline is shown in Figure 1.

Drugs and chemicals
Bleomycin sulphate (bleo) was purchased from Enzo Life
Sciences (New York, United States). Bleo was dissolved in saline
for intra-tracheal administration. This procedure was performed
within the animal housing center.

Rat model of lung injury
Rats were randomized into three experimental groups and
lung parameters were measured at ﬁve time points- before
(W0) and post-instillation (W1, 2, 3 and 4) as follows: sham
rats (n = 14), low-dose bleo-treated rats (n = 10) and highdose bleo-treated rats (n = 9). Bleo (2.5 mg/kg (high-dose) and
1.25 mg/kg (low-dose), ~0.15 ml) was instilled on day 1 intratracheally under 2%–3% isoﬂurane anesthesia. Sham control
animals underwent intra-tracheal instillation of saline
(~0.15 ml).

Breathing and ventilatory chemoreﬂex
function at rest
Unrestrained whole-body plethysmography was utilized to
measure ventilatory parameters- respiratory rate (fR), tidal
volume (Vt) and minute ventilation (VE) in conscious rats by
using signals from differential-pressure transducer (DLP 2.5,
Harvard Apparatus), ampliﬁed and connected to PC via
acquisition system PowerLab 35 Series managed by LabChart
(v8.1.5) software (ADInstruments, Colorado, United States). Rats
were acclimated to the plethysmograph chamber for 1 h each for
two consecutive days prior to recordings. Respiratory parameters
were not recorded during the acclimatization sessions. The
plethysmograph chambers used for this study were custommade (Midwest Plastics Inc., Nebraska, United States) and
were 10, 10.5 and 20 cm in height, width, and length,
respectively. The volume channel (i.e., ﬂow integration) was
calibrated by pushing 5 ml of air using a syringe before the
start of the recording. During recordings, a constant ﬂow of gas at
3 L/min was maintained to avoid an increase in humidity,
temperature and CO2 levels using a manually operated ﬂow
meter (Precision Medical, Northampton, PA, United States).
Body weight (in grams) of rats was recorded prior to each
experiment. In the resting state rats were exposed to
normoxia (21% O2, 0% CO2) for baseline measurements
followed by three different gas challenges- hyperoxia (90% O2,
0% CO2), hypoxia (10% O2, 0% CO2) and normoxic hypercapnia
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FIGURE 2
Representative recordings of resting breathing at normoxia (on left) and 10% hypoxia (on right) obtained in one rat per experimental group: (A)
and (B) Sham (in green) at W0 and W1, respectively; (C) and (D) low-dose bleo (in purple) at W0 and W1, respectively; (E) and (F) high-dose bleo (in
blue) at W0 and W1, respectively.

(21% O2, 5% CO2) balanced by N2. The order of gas challenge
was randomized and was maintained for 5 min. The last oneminute-long segment without any artifacts was used for analysis.
A normoxic exposure of a minimum of 10 min or more was used
in between challenges. All resting ventilatory parameters
considered for analysis were recorded when the rats were
awake and stationary (no activity-related events recorded in
LabChart8 raw data ﬁle). VE was calculated as the product of
fR and Vt. Vt and VE were normalized to bodyweight.

saline) treatment with W0 (pre-treatment) within each
experimental group was done using one-way ANOVA with
bonferroni multiple comparison test with p < 0.05 being
statistically signiﬁcant.

Statistical analysis

Body weights were measured weekly in all rats pre- (W0) and
post-saline/bleo instillation (W1, 2, 3 and 4). At W1-post-bleo
instillation, low-dose bleo-treated rats (∆ body weight at
W1 post-ALI = 6.6 ± 50 g) showed no signiﬁcant changes but
high-dose bleo-treated rats (∆ body weight at W1 postALI = −19 ± 20 g) showed a reduction in body weight that
was not statistically signiﬁcant when compared to change in body
weight in sham rats at W1-post-saline/bleo instillation (∆ body
weight from W0 to W1 post-ALI = 69 ± 20 g) (Table 1). Sham
and low-dose bleo-treated rats continued to gain weight each
week throughout the experimental timeline (Table 1; Figure 1).

Data analysis in text, tables and ﬁgures are presented as
mean ± SD. Statistical evaluation was analyzed using GraphPad
Prism (GraphPad Software, San Diego, CA. Version 8).
Comparisons between conditions (gas challenges) and for
comparisons between groups (Sham, low-dose bleo and, highdose bleo) repeated-measures two-way ANOVA with bonferroni
corrections for multiple comparisons were used with p <
0.05 being statistically signiﬁcant. For tables, the comparison
of body weight and resting fR at each timepoint post-drug (bleo/

Results
Effects of saline and bleomycin on body
weight in rats
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FIGURE 3
Effect of saline and (low-dose and high-dose) bleomycin on ventilatory parameters in sham (n = 14), low-dose bleo (n = 10) and high-dose bleo
(n = 9) rats. Two-way ANOVA, Values are mean ± SD: (A) Respiratory rate (fR) at normoxia vs. 10%; (B) Tidal volume (Vt) at normoxia vs. 10% hypoxia;
(C) Minute ventilation (VE) at normoxia vs. 10% hypoxia.

High-dose bleo-treated rats gained weight by the end of W3 and
W4 (Table 1). One high dose bleo-treated rat died at W2.

Bleomycin caused an increase in resting fR
As noted in Figures 2, 3A and Table 2 Sham rats showed a
consistent normal resting fR (180 ± 12 bpm) at W1 post-saline
administration compared to W0 (104 ± 15 bpm). On the other
hand, resting fR increased (p < 0.0001) in both low-dose bleo-

(193 ± 55 bpm) and high-dose bleo-treated rats (333 ± 46 bpm)
at W1 post-bleo administration as compared to their baseline at
W0 (low-dose group = 97 ± 16 bpm and high-dose group =
117 ± 21 bpm). The resting fR in low- and high-dose bleo rats
was partially restored by W3 (127 ± 32 bpm and 166 ± 40 bpm,
respectively) and W4 (108 ± 7 bpm and 144 ± 30 bpm,
respectively). These changes in resting fR also inﬂuenced
similar trends in resting VE (Figures 3C, 4C). No signiﬁcant
changes were seen for the change in Vt in either group (Figures
3B and 4B).
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FIGURE 4
(A) Delta fR; (B) Delta Vt; (C) Delta VE in response to 10% hypoxia in sham (n = 14), low-dose bleo (n = 10) and high-dose bleo (n = 9) rats.

Effects of hypoxia on respiration
The peripheral chemoreﬂex was activated by challenging the
rats with 10% hypoxia for a duration of 5 min and ventilatory
parameters were assessed. The chemoreﬂex was assessed by
measuring the absolute difference between 21% O2/0% CO2
and 10% O2/0% CO2. At baseline (W0), fR increased in
response to 10% O2 in sham, low-dose and high-dose bleotreated rats by 63 ± 29 bpm, 66 ± 18 bpm and 64 ± 21 bpm,
respectively, before saline and bleo administration on day 1
(Figures 2A, 4A). 1W- post-saline/bleo administration, sham
rats continued to respond normally to 10% hypoxic gas
challenge. While the low-dose bleo-treated rats exhibited an
activation of the chemoreﬂex with a signiﬁcant increase in fR
(∆fR = 93 ± 31 bpm, p < 0.0001). The high-dose bleo-treated rats,
on the other hand, exhibited a signiﬁcant blunting of the
chemoreﬂex response (∆fR = −0.97 ± 42 bpm, p < 0.0001)
compared to sham rats with ∆ fR of 70 ± 41 bpm at 1Wpost-bleo administration (Figures 2A, 4A).
For the high-dose bleo-treated rats, changes in VE (∆VE)
were not statistically signiﬁcant (p = 0.8). However, we see a
pattern of blunted ∆VE at W1 (∆VE = 57 ± 18 ml/min/Kg and
14 ± 35 ml/min/Kg in sham and high-dose bleo-treated rats,
respectively) due to a blunted ∆fR without signiﬁcant changes in
∆Vt (Figure 4C). Sham rats continued to show a normal and
consistent chemoreﬂex activation at W2 (∆fR = 42 ± 19 bpm),
W3 (∆fR = 41 ± 19 bpm) and W4 (∆fR = 50 ± 17 bpm). Low-dose
bleo-treated rats exhibited an increased chemoreﬂex activation at

W2 (∆fR = 105 ± 26 bpm, p = 0.02) and a signiﬁcant sensitization
at W3 (∆fR = 100 ± 37 bpm, p = 0.03) and at W4 (∆fR = 94 ±
31 bpm, p = 0.006) when compared to the sham group for
respective time points (Figure 4A). High-dose bleo-treated rats
showed a restoration in chemoreﬂex activation at W2 (∆fR = 69 ±
91 bpm) and show a chemoreﬂex sensitization at W3 (∆fR =
114 ± 43 bpm, p = 0.007) and W4 (∆fR = 132 ± 58 bpm, p = 0.001)
when compared to the sham group for respective time points
(Figure 4A). Similar trends were observed for ∆VE in all
experimental groups (Figure 4C). It is important to note that
irrespective of the dose of bleomycin, there was sensitization of
chemoreﬂex around W3 and 4. Vt was not signiﬁcantly changed
in either group (Figure 4B).

Effects of normoxic-hypercapnia on
respiration
In the same groups of rats, both peripheral and central
chemoreﬂexes were activated by challenging the rats with 5%
CO2/21% O2 for a duration of 5 min. The chemoreﬂex was
assessed by measuring the absolute difference between 21% O2/
0% CO2 and 21% O2/5% CO2. At baseline (W0), fR was
increased in both sham and bleo-treated rats (low-dose and
high-dose) by 62 ± 33 bpm, 66 ± 28 bpm and 63 ± 28 bpm
before saline or bleo administration, respectively (Figures 5A,
6A). At W1 post-saline/bleo administration, sham rats
continued to respond normally to 5% hypercapnic/21%
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FIGURE 5
Effect of saline and (low-dose and high-dose) bleomycin on ventilatory parameters in sham (n = 14), low-dose bleo (n = 10) and high-dose bleo
(n = 9) rats. Two-way ANOVA, Values are mean ± SD: (A) Respiratory rate (fR) at normoxia vs. normoxic-hypercapnia; (B) Tidal volume (Vt) at normoxia
and normoxic-hypercapnia; (C) Minute ventilation (VE) at normoxia vs. normoxic-hypercapnia.

normoxic gas challenge (∆fR = 77 ± 59 bpm). The low-dose
bleo-treated rats exhibit a chemoreﬂex response to normoxichypercapnia (∆fR = 74 ± 37 bpm) while the high-dose bleotreated group showed a blunted chemoreﬂex response by a
signiﬁcant reduction in ∆fR to 8 ± 51 bpm (p = 0.004) compared
to its timed-control (sham rats at W1) (Figure 6A). This blunted
chemoreﬂex response was similar to the blunted peripheral
chemoreﬂex response 1W post-bleo instillation.
Changes in ∆VE showed a similar blunted pattern in bleotreated rats at W1 (∆VE = 49 ± 25 ml/min/Kg, 46 ± 34 ml/min/Kg
and 22 ± 40 ml/min/Kg in sham, low-dose, and high-dose bleotreated rats, respectively) (Figures 5C and 6C) due to increased fR
without signiﬁcant changes in Vt (Figures 5B and 6B) but were

not statistically signiﬁcant. Sham rats continued to show normal
chemoreﬂex activation at W2 (∆fR = 52 ± 32 bpm), W3 (53 ±
24 bpm) and W4 (42 ± 16 bpm). Although not statistically
signiﬁcant, low-dose bleo-treated rats showed a pattern of
sensitized chemoreﬂex at W2 (93 ± 36 bpm), W3 (85 ±
35 bpm) and W4 (100 ± 92 bpm) just as seen for the
peripheral chemoreﬂex in response to 10% hypoxia
(Figure 6A). High-dose bleo-treated rats showed a restoration
in chemoreﬂex activation at W2 (67 ± 71 bpm) and 3 (64 ±
35 bpm) and was sensitized at W4 (100 ± 92 bpm, p = 0.01)
(Figure 6B). Similar trends were observed for ∆VE in both
experimental groups throughout the experimental timeline
(Figure 6C).
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FIGURE 6
(A) Delta fR; (B) Delta Vt; (C) Delta VE in response to normoxic-hypercapnia in sham (n = 14), low-dose bleo (n = 10) and high-dose bleo (n = 9)
rats.

Effects of hyperoxia on respiration 1-week
post-bleo instillation
To inhibit tonic chemoreﬂex activation at rest, sham and bleo
rats were exposed to 90% O2/0% CO2 gas mixture at W1 and
ventilatory parameters were evaluated. No signiﬁcant change in
fR was seen. (Figure 7A). 1W post-saline/bleo instillation (lowand high-dose), ∆fR for sham vs. low dose and high-dose bleotreated rats was 8 ± 12 bpm, −4 ± 16 bpm and −6 ± 17 bpm,
respectively (Figure 7B). No signiﬁcant changes were seen for Vt
in either group (Figures 7C,D). VE was signiﬁcantly higher in
high-dose bleo group when compared to sham and low-dose bleo
group (Figures 7E,F).

Discussion
The major ﬁndings of the present study are as follows: 1)
both low-dose and high-dose bleo-treated rats showed a
signiﬁcant increase in resting fR W1 post-bleo administration
which was partially restored to normal by W3 and 4; 2) In
response to 10% hypoxia and 5% normoxic-hypercapnia, while
low-dose bleo-treated rats exhibited an activated peripheral
chemoreﬂex response, the high-dose bleo-treated rats showed
a blunted chemoreﬂex response at W1 post-bleo
administration; 3) At W3 and 4, post-recovery from ALI, in
response to 10% hypoxia and 5% normoxic-hypercapnia, both
low-dose and high-dose bleo-treated rats exhibited a sensitized
chemoreﬂex response; 4) In response to hyperoxia (90% O2),

both low-dose and high-dose treated bleo rats showed no
signiﬁcant reduction in the increased fR at W1 post-bleo
administration.
Shortness of breath and an increase in resting fR caused by
impairment of gas exchange are the main characteristics of ALI/
ARDS which accounts for 10% of ICU admissions and has a
high mortality rate (Mowery et al., 2020). Impaired gas
exchange in ALI stimulates chemoreﬂex activation (Jacono
et al., 2006). A time-course study of changes in chemoreﬂex
activation during ALI has never been explored. The present
study assesses the functional changes in chemoreﬂex activation
over a 4-week time-course fashion from the beginning of ALI
and during its recovery.
There are multiple ALI animal models reported in the
scientiﬁc literature (Matute-Bello et al., 2008). However, no
single model is the “best” model for ALI. We utilized the bleo
model, which is widely used to model ALI (Moore and
Hogaboam, 2008). Intra-tracheal administration of bleo
damages the alveolar endothelium (Matute-Bello et al.,
2008). Two different doses of bleo were used with the aim to
study differences in the severity of ALI. Other common ALI
animal models include the LPS model, which is also very
reproducible and is widely used to study ALI (Zeng et al.,
2017; Ye and Liu, 2020; Hou et al., 2021). Unfortunately, for
the purpose of our current study, it could not be used because
LPS is known to directly affect the sympathetic and
parasympathetic ganglia (Shadiak et al., 1994; Hosoi et al.,
2005; Kunda et al., 2014; Blum et al., 2017; Boucher et al.,
2018) and for this reason, we think that LPS alone could directly
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FIGURE 7
Effect of 90% hyperoxia on ventilatory parameters in sham (n = 10), low-dose bleo (n = 10) and high-dose bleo (n = 6) rats at W0 and W1. Twoway ANOVA, Values are mean ± SD: (A) Respiratory rate (fR) at normoxia vs. 90% hyperoxia; (B) Delta fR; (C) Tidal volume (Vt) at normoxia vs. 90%
hyperoxia; (D) Delta Vt; (E) Minute ventilation (VE) at normoxia and 90% hyperoxia; (F) Delta VE.

interfere with the function of the carotid bodies thus
confounding the primary goal of examining the effect of ALI
on the chemoreﬂex.
Poor gas exchange caused by disruption of the normal
alveolar-capillary endothelial barrier in this disease condition
leads to systemic hypoxemia that is known to activate the
peripheral chemoreceptors, which is one of the primary
defense mechanisms to restore normal gas levels in the
body (Dias-Freitas et al., 2016). Although there are some
studies that provide possible mechanistic explanations but

the neural mechanism(s) that drive the increase in f R are not
fully understood. The existing literature provides evidence
that the chemoreﬂex function is altered during ALI (Jacono
et al., 2006; Huxtable et al., 2011). A study by Jacono et al.,
2006 showed that the chemoreﬂex, 5 days post-ALI, was
sensitized in bleo-treated rats. This is consistent with what
we see in our W1 post-low-dose bleo treated rats. Another
study by Huxtable et al., 2012 used an LPS-ALI rat model to
show an increase in resting fR and a blunted chemoreﬂex
response to 10.5% O2, 7%CO2 gas challenge at day 1 post-LPS
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(i.p.) treatment. Our study showed that at W1 post-bleo
treatment, while the low-dose bleo-treated rats exhibited a
pattern of sensitized chemoreﬂex activity, the high-dose bleotreated rats on the other hand exhibited a blunted chemoreﬂex
response to 10% hypoxia. We initially thought that this may be
possible due to a “ceiling effect”, meaning that the
chemoreﬂex could be maximally activated at baseline
breathing normal (21% O 2) air. This possibility was ruled
out by exposing the bleo-rats to hyperoxia with the goal to
inhibit the chemoreﬂex (Figures 7A,B). Interestingly, we did
not see a change in fR in that group of rats. It is important to
note that in this study, we are testing the chemoreﬂex
activation in response to hypoxia, and both peripheral and
central chemoreﬂex activation in response to normoxichypercapnia as a stimulus. We know that the CBs also get
activated by changes in pH level which can act as a potential
stimulus for chemoreﬂex activation in ALI condition. We have
previously provided evidence that compared to vehicletreated rats, bleo rats exhibit signiﬁcantly decreased blood
pO2 and sO2 at W1 post-bleo, indicating severe hypoxemia
during acute lung injury. Bleo rats also exhibit elevated pCO2
and decreased pH at W1 post-bleo, indicating blood acidosis
(Kitzerow et al., 2022). Therefore, the role of other stimuli
(such as, pH) in tonic activation of chemoreceptors during
severe ALI condition require further investigation.
During the recovery from ALI, there was a partial
restoration of the resting fR in bleo rats at W3 and W4.
Histological proof of recovery from ALI post-intratracheal
delivery of bleo has shown by many groups over the years
(Moore and Hogaboam, 2008; Young et al., 2019; Mahmutovic
Persson et al., 2020). Interestingly, at W3 and W4 post-ALI, the
chemoreﬂex was sensitized in response to hypoxia and
normoxic-hypercapnia in both low-dose- and high-dose bleo
groups. We show for the ﬁrst time to our knowledge, that
chemoreﬂex activity during recovery from ALI is sensitized.
The present study did not explore what causes the chemoreﬂex
to be sensitized during recovery from ALI. It is possible that this
may be attributed to multiple effects mediated at one or more
levels of the reﬂex arc. Although the recovery phase of the ALI
has not been extensively studied in terms of mechanisms for
sensitized chemoreﬂex activity, it is already known that ALI
inﬂuences both the pattern and the rhythm of breathing. In
early stages of ALI (W1 post-bleo), Jacono et al. detected
increased immunoreactivity of the pro-inﬂammatory
cytokine interleukin-1β in the NTS from ALI rats. Bilateral
micro-injections of IL-1β in the NTS of naïve rats showed
increased fR similar to that found in rats with ALI. They
speculated that though initiated by sensory input, the
characteristic ventilatory pattern after lung injury may be
mediated by neuro-inﬂammation by cytokines in the NTS
(Getsy et al., 2019; Hsieh et al., 2020; Litvin et al., 2020).
Based on their evidence, it would not be surprising to expect
similar plasticity in the NTS during the recovery stages of ALI.
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Our lab previously provided evidence of neuroinﬂammation
and altered (increased) neuronal excitability in the stellate
ganglia during the recovery phase of bleo-induced ALI
(Hong et al., 2021). Based on this and our data for sensitized
chemoreﬂex response to hypoxic stimulus, it is reasonable to
speculate that similar neuroinﬂammation is possible in the
carotid bodies which could lead to an altered chemoreﬂex
function in this disease condition. In addition, a similar
mechanism could also be possible in the superior cervical
ganglion (SCG) that is located on the same sympathetic
chain as the stellate ganglia. The post ganglionic axons of
the SCG are known to innervate the CBs (Iturriaga et al.,
2016). Electrical stimulation of the SCG has been shown to
signiﬁcantly sensitize the CB chemoreﬂex in hypertensive and
normotensive rats (Felippe and Paton, 2021; Getsy et al., 2021;
Felippe et al., 2022). Therefore, an increased SCG neuronal
activity during the recovery of ALI, in-part, might also
contribute to chemoreﬂex sensitization observed in our
study. In addition, systemic hypoxia is a major consequence
in chronic heart failure (CHF) condition (Morrissey et al., 2011)
and studies provide evidence that experimental models of CHF
(Andrade et al., 2015) and CHF patients (Giannoni et al., 2009)
exhibit sensitized chemoreﬂex that contributes to sympathoexcitation and disordered breathing (Morrissey et al., 2011).
Like CHF, ALI also leads to systemic hypoxia and a sensitized
chemoreﬂex function in response to hypoxia. In addition, the
increase in Ang II-dependent oxidative stress has been shown to
contribute to altered CB function in CHF (Andrade et al., 2015).
Interestingly, studies show that ALI results in decreased
ACE2 expression and increased production of Ang II in the
acid aspiration mice model of ALI (Imai et al., 2005). Therefore,
Ang II signaling could be a potential mechanism causing
sensitized chemoreﬂex during the recovery phase of ALI.

Conclusion
In summary, this study provides evidence that in the early
phase of ALI, the chemoreﬂex is sensitized during low-dose ALI
(moderate ALI) and blunted during high-dose bleo ALI (severe
ALI). More importantly, it brings attention to the novel discovery
of a sensitized chemoreﬂex during recovery from both moderate
and severe ALI. The chemoreﬂexes are important modulators of
sympathetic activation. It is well established that acute and/or
chronic activation of the –chemoreﬂex enhances sympathetic
drive (Plataki et al., 2013). Excessive sympathetic outﬂow can
lead to cardiac arrythmias, cardio-renal syndrome, metabolic
syndrome, T2 diabetes and deterioration of cardiac function
(Paton et al., 2013; Conde et al., 2014; Iturriaga et al., 2016;
Del Rio et al., 2017; Cunha-Guimaraes et al., 2020). Therefore,
identiﬁcation and further understanding of the neural
mechanism that mediates changes in chemoreﬂex function
during early and late stages of ALI will provide important
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information for the long-term goal of development of novel
targeted therapeutic approaches to improve clinical outcomes.

Data availability statement
The original contributions presented in the study are
included in the article/Supplementary Material, further
inquiries can be directed to the corresponding author.

Ethics statement
The animal study was reviewed and approved by the
Institutional Animal Care and Use Committee (IACUC) of
the University of Nebraska Medical Center.

Author contributions
KK, RA, and NK generated the data. KK analyzed the data and
wrote the original draft manuscript. IZ, HS, and H-JW conceptually
designed the study and reviewed, edited, and ﬁnalized the manuscript.
All authors contributed to the article and approved the submitted
version.

10.3389/fphys.2022.1009607

Funding
This study was supported by NIH grant R01 HL-152160 and
in part, by NIH grants R01 HL-121012 and R01 HL126796. HJW is also supported by Margaret R. Larson Professorship in
Anesthesiology. IZ was partially supported by the Theodore F.
Hubbard Foundation. KK is supported by American Heart
Association predoctoral fellowship (ID:903872).

Conﬂict of interest
The authors declare that the research was conducted in the
absence of any commercial or ﬁnancial relationships that could
be construed as a potential conﬂict of interest.

Publisher’s note
All claims expressed in this article are solely those of the
authors and do not necessarily represent those of their afﬁliated
organizations, or those of the publisher, the editors and the
reviewers. Any product that may be evaluated in this article, or
claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.

References
Andrade, D. C., Lucero, C., Toledo, C., Madrid, C., Marcus, N. J., Schultz, H.
D., et al. (2015). Relevance of the carotid body chemoreﬂex in the
progression of heart failure. Biomed. Res. Int. 2015, 467597. doi:10.1155/
2015/467597
Bernard, G. R., ArtigAs, A., Brigham, K. L., Carlet, J., FalKe, K., Hudson, L., et al.
(1994). The American-European Consensus Conference on ARDS. Deﬁnitions,
mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit.
Care Med. 149 (3), 818–824. doi:10.1164/ajrccm.149.3.7509706

Felippe, I. S., Zera, T., da Silva, M. P., Moraes, D. J. A., McBryde, F., and Paton,
J. F. R. (2022). The sympathetic nervous system exacerbates carotid body sensitivity
in hypertension. Cardiovasc. Res. 2022, cvac008. doi:10.1093/cvr/cvac008
Getsy, P. M., Coffee, G. A., Hsieh, Y. H., and Lewis, S. J. (2021). Loss of cervical
sympathetic chain input to the superior cervical ganglia affects the ventilatory
responses to hypoxic challenge in freely-moving C57BL6 mice. Front. Physiol. 12,
619688. doi:10.3389/fphys.2021.619688

Blum, E., Procacci, P., Conte, V., Sartori, P., and HananiM. (2017). Long term
effects of lipopolysaccharide on satellite glial cells in mouse dorsal root ganglia.
Exp. Cell Res. 350 (1), 236–241. doi:10.1016/j.yexcr.2016.11.026

Getsy, P. M., Mayer, C. A., MacFarlane, P. M., Jacono, F. J., and Wilson, C. G.
(2019). Acute lung injury in neonatal rats causes postsynaptic depression in nucleus
tractus solitarii second-order neurons. Respir. Physiol. Neurobiol. 269, 103250.
doi:10.1016/j.resp.2019.103250

Boucher, Y., Moreau, N., Mauborgne, A., and Dieb, W. (2018).
Lipopolysaccharide-mediated inﬂammatory priming potentiates painful posttraumatic trigeminal neuropathy. Physiol. Behav. 194, 497–504. doi:10.1016/j.
physbeh.2018.06.021

Ghio, S., GavAzzi, A., Campana, C., Inserra, C., Klersy, C., Sebastiani, R., et al.
(2001). Independent and additive prognostic value of right ventricular systolic
function and pulmonary artery pressure in patients with chronic heart failure.
J. Am. Coll. Cardiol. 37 (1), 183–188. doi:10.1016/s0735-1097(00)01102-5

Conde, S. V., Sacramento, J. F., Guarino, M. P., Gonzalez, C., Obeso, A., Diogo, L.
N., et al. (2014). Carotid body, insulin, and metabolic diseases: Unraveling the links.
Front. Physiol. 5, 418. doi:10.3389/fphys.2014.00418

Giannoni, A., Emdin, M., Bramanti, F., Iudice, G., Francis, D. P., Barsotti, A., et al.
(2009). Combined increased chemosensitivity to hypoxia and hypercapnia as a
prognosticator in heart failure. J. Am. Coll. Cardiol. 53 (21), 1975–1980. doi:10.
1016/j.jacc.2009.02.030

Cunha-Guimaraes, J. P., Guarino, M. P., Timoteo, A. T., Caires, I., Sacramento,
J. F., Ribeiro, M. J., et al. (2020). Carotid body chemosensitivity: Early biomarker of
dysmetabolism in humans. Eur. J. Endocrinol. 182 (6), 549–557. doi:10.1530/EJE19-0976
Del Rio, R., Andrade, D. C., Toledo, C., Diaz, H. S., Lucero, C., Arce-Alvarez, A.,
et al. (2017). Carotid body-mediated chemoreﬂex drive in the setting of low and
high output heart failure. Sci. Rep. 7 (1), 8035–8110. doi:10.1038/s41598-01708142-3
Dias-Freitas, F., Metelo-Coimbra, C., and Roncon-Albuquerque, R., Jr (2016).
Molecular mechanisms underlying hyperoxia acute lung injury. Respir. Med. 119,
23–28. doi:10.1016/j.rmed.2016.08.010
Felippe, I., and Paton, J. (2021). Sympathetic control of carotid body
sympathoexcitatory reﬂex responsiveness in spontaneously hypertensive rats.
FASEB J. 35, 03247. doi:10.1096/fasebj.2021.35.s1.03247

Hong, J., Adam, R. J., Gao, L., Hahka, T., Xia, Z., Wang, D., et al. (2021).
Macrophage activation in stellate ganglia contributes to lung injury-induced
arrhythmogenesis in male rats. Acta Physiol. 232 (2), e13657. doi:10.1111/apha.
13657
Hosoi, T., Okuma, Y., Matsuda, T., and Nomura, Y. (2005). Novel pathway for
LPS-induced afferent vagus nerve activation: Possible role of nodose ganglion.
Auton. Neurosci. 120 (1-2), 104–107. doi:10.1016/j.autneu.2004.11.012
Hou, L., Zhang, J., Liu, Y., Fang, H., Liao, L., Wang, Z., et al. (2021). MitoQ
alleviates LPS-mediated acute lung injury through regulating Nrf2/
Drp1 pathway. Free Radic. Biol. Med. 165, 219–228. doi:10.1016/j.
freeradbiomed.2021.01.045
Hsieh, Y. H., Litvin, D. G., Zaylor, A. R., Nethery, D. E., Dick, T. E., and Jacono, F.
J. (2020). Brainstem inﬂammation modulates the ventilatory pattern and its

Kamra et al.

variability after acute lung injury in rodents. J. Physiol. 598 (13), 2791–2811. doi:10.
1113/JP279177
Huxtable, A., Vinit, S., Windelborn, J. A., Crader, S. M., Guenther, C. H., Watters,
J. J., et al. (2011). Systemic inﬂammation impairs respiratory chemoreﬂexes and
plasticity. Respir. Physiol. Neurobiol. 178 (3), 482–489. doi:10.1016/j.resp.2011.
06.017

10.3389/fphys.2022.1009607

Morrissey, R. P., Czer, L., and Shah, P. K. (2011). Chronic heart failure: Current
evidence, challenges to therapy, and future directions. Am. J. Cardiovasc. Drugs 11
(3), 153–171. doi:10.2165/11592090-000000000-00000
Mowery, N. T., Terzian, W. H., and Nelson, A. C. (2020). Acute lung injury. Curr.
Probl. Surg. 57 (5), 100777. doi:10.1016/j.cpsurg.2020.100777

Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., et al. (2005). Angiotensinconverting enzyme 2 protects from severe acute lung failure. Nature 436 (7047),
112–116. doi:10.1038/nature03712

Paton, J. F., Sobotka, P. A., Fudim, M., Engelman, Z. J., Engleman, Z. J., Hart, E. C.
J., et al. (2013). The carotid body as a therapeutic target for the treatment of
sympathetically mediated diseases. Hypertension 61 (1), 5–13. doi:10.1161/
HYPERTENSIONAHA.111.00064

Iturriaga, R., Rio, R. D., Idiaquez, J., and Somers, V. K. (2016). Carotid body
chemoreceptors, sympathetic neural activation, and cardiometabolic disease. Biol.
Res. 49, 13. doi:10.1186/s40659-016-0073-8

Plataki, M., Sands, S. A., and Malhotra, A. (2013). Clinical consequences of altered
chemoreﬂex control. Respir. Physiol. Neurobiol. 189 (2), 354–363. doi:10.1016/j.
resp.2013.04.020

Jacono, F. J., Peng, Y. J., Nethery, D., Faress, J. A., Lee, Z., Kern, J. A., et al. (2006).
Acute lung injury augments hypoxic ventilatory response in the absence of systemic
hypoxemia. J. Appl. Physiol. 101 (6), 1795–1802. doi:10.1152/japplphysiol.00100.2006

Prabhakar, N. R. (2000). Oxygen sensing by the carotid body chemoreceptors.
J. Appl. Physiol. 88 (6), 2287–2295. doi:10.1152/jappl.2000.88.6.2287

Kitzerow, O., Zucker, I. H., Lisco, S. J., and Wang, H. J. (2022). Timeline of multiorgan plasma extravasation after bleomycin-induced acute lung injury. Front.
Physiol. 13, 777072. doi:10.3389/fphys.2022.777072
Kunda, P. E., Cavicchia, J. C., and Acosta, C. G. (2014). Lipopolysaccharides and
trophic factors regulate the LPS receptor complex in nodose and trigeminal
neurons. Neuroscience 280, 60–72. doi:10.1016/j.neuroscience.2014.08.053
Litvin, D. G., Denstaedt, S. J., Borkowski, L. F., Nichols, N. L., Dick, T. E., Smith,
C. B., et al. (2020). Peripheral-to-central immune communication at the area
postrema glial-barrier following bleomycin-induced sterile lung injury in adult
rats. Brain Behav. Immun. 87, 610–633. doi:10.1016/j.bbi.2020.02.006
Mahmutovic Persson, I., Falk Hakansson, H., Orbom, A., Liu, J., von
Wachenfeldt, K., and Olsson, L. E. (2020). Imaging biomarkers and
pathobiological proﬁling in a rat model of drug-induced interstitial lung disease
induced by bleomycin. Front. Physiol. 11, 584. doi:10.3389/fphys.2020.00584
Matute-Bello, G., Frevert, C. W., and Martin, T. R. (2008). Animal models of
acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295 (3), L379–L399. doi:10.
1152/ajplung.00010.2008
Moore, B. B., and Hogaboam, C. M. (2008). Murine models of pulmonary ﬁbrosis.
Am. J. Physiol. Lung Cell. Mol. Physiol. 294 (2), L152–L160. doi:10.1152/ajplung.
00313.2007

Shadiak, A. M., Carlson, C. D., DingM.Hart, R. P., and Jonakait, G. M. (1994).
Lipopolysaccharide induces substance P in sympathetic ganglia via ganglionic
interleukin-1 production. J. Neuroimmunol. 49 (1-2), 51–58. doi:10.1016/01655728(94)90180-5
Spinelli, E., Mauri, T., Beitler, J. R., Pesenti, A., and Brodie, D. (2020). Respiratory
drive in the acute respiratory distress syndrome: Pathophysiology, monitoring, and
therapeutic interventions. Intensive Care Med. 46 (4), 606–618. doi:10.1007/s00134020-05942-6
Sun, S.-Y., Wang, W., Zucker, I. H., and Schultz, H. D. (1999). Enhanced
peripheral chemoreﬂex function in conscious rabbits with pacing-induced heart
failure. J. Appl. Physiol. 86 (4), 1264–1272. doi:10.1152/jappl.1999.86.4.1264
Ye, R., and Liu, Z. (2020). ACE2 exhibits protective effects against LPS-induced
acute lung injury in mice by inhibiting the LPS-TLR4 pathway. Exp. Mol. Pathol.
113, 104350. doi:10.1016/j.yexmp.2019.104350
Young, B. P., Loparo, K. A., Dick, T. E., and Jacono, F. J. (2019). Ventilatory
pattern variability as a biometric for severity of acute lung injury in rats. Respir.
Physiol. Neurobiol. 265, 161–171. doi:10.1016/j.resp.2019.03.009
Zeng, M., Sang, W., Chen, S., Chen, R., Zhang, H., Xue, F., et al. (2017). 4-PBA
inhibits LPS-induced inﬂammation through regulating ER stress and autophagy
in acute lung injury models. Toxicol. Lett. 271, 26–37. doi:10.1016/j.toxlet.2017.
02.023

